Artivion to Participate in the 2026 Truist Securities MedTech Conference
Rhea-AI Summary
Artivion (NYSE:AORT) will participate in the 2026 Truist Securities MedTech Conference on June 16, 2026, at the Boston Harbor Hotel.
The company will host a fireside chat at 1:00 p.m. ET, with a live and archived webcast available on its investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – AORT
In the Jun 11 session, AORT gained 0.64%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.
About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.
Contacts: | |
Artivion | Gilmartin Group LLC |
Lance A. Berry | Brian Johnston |
Executive Vice President, | Phone: 332-895-3222 |
Chief Operating Officer & | |
Chief Financial Officer | |
Phone: 770-419-3355 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-the-2026-truist-securities-medtech-conference-302797227.html
SOURCE Artivion, Inc.